Newsroom

Newsroom

Headline

  • CAS Academician ZHANG Tao Wins 2025 Citation Laureate Award

    On September 25, Clarivate Analytics announced the winners of the 2025 Citation Laureate Award, recognizing a total of 22 distinguished scholars from eight countries. Among them, ZHANG Tao, Academician of the Chinese Academy of Sciences (CAS) was named a Citation Laureate in Chemistry, making history as the first scientist from mainland China to receive this recognition.

    Fig. The picture of ZHANG Tao Wins 2025 Citation Laureate Award.

    ZHANG was honored for his seminal contributions to single-atom catalysis. He was the first to coin the concept of Single-Atom Catalysis, advancing heterogeneous catalysis research to the atomic scale, laying the scientific foundation for precision catalysis, and opening an entirely new frontier in the field.

    His groundbreaking research in single-atom catalysis has not only driven fundamental advances in catalysis science but also profoundly influenced several frontier interdisciplinary fields, including energy chemistry and materials science. His research has further stimulated rapid global progress in this area of research.

    Media Contact:
    LI Xiangyu
    Public Information Officer
    Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, P. R. China.
    E-mail: xiangyuli@ipe.ac.cn
    Tel: 86-10-82544826

    附件下载

    Recommended Articles
    Chinese Researchers Crack Tough Challenge of Low-grade Iron Ore Utilization
    Chinese Researchers Crack Tough Challenge of Low-grade Iron Ore Utilization
    Sep 03,2026
    A breakthrough technology that converts hard-to-process iron ore into high-grade concentrate has been deployed at the world's largest, marking a major milestone in China's effort to reduce its reliance on imported iron ore.
    Researchers Develop a Biomimetic Platform to Enhance CAR T Cell Therapy Against Leukemia
    Mar 04,2026
    Researchers have developed a dual-functional cell engager that combines cell bridging and targeted chemotherapeutic delivery to improve chimeric antigen receptor T (CAR T) cell therapy for relapsed and refractory leukemias.

    CONTACT US

    • CONTACT US 86-10-82544817
    • CONTACT US 62551257
    • CONTACT US ghb@ipe.ac.cn
    • CONTACT US Institute of Process Engineering,Chinese Academy of Sciences,1 North 2nd Street, Zhongguancun, Haidian District, Beijing 100190, PR China